Publications by authors named "Tasha Phillips Wilson"
Leaflet thrombosis after transcatheter aortic valve replacement (TAVR) presents a significant challenge, leading to adverse clinical outcomes. Subclinical leaflet thrombosis (SLT) is increasingly recognized, and there is a growing concern about its role in clinical events and hemodynamic valve deterioration. Current recommendations for prophylactic anticoagulation or antiplatelet therapy following TAVR are primarily based on expert consensus rather than definitive evidence from randomized trials, resulting in a variety of antithrombotic strategies in clinical practice.
View Article and Find Full Text PDFArticle Synopsis
- The review highlights the challenges of managing antithrombotic therapy for atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI), emphasizing the need to balance the prevention of ischemic events and minimizing bleeding risks.
- It spans research from 2010 to October 2023 and calls for personalized treatment strategies to optimize antithrombotic therapy in these patients.
- The expert opinion favors double antithrombotic therapy (DAT) over triple therapy (TAT) for better safety without compromising effectiveness, recommending NOAC-based DAT post-PCI while addressing ongoing challenges in specific patient groups.
Cardiovascular (CV) outcomes can be improved with commonality between provider and patient regarding gender and race/ethnicity. Slow growth in CV care provider diversity is an obstacle for women and underrepresented groups. The hope for more equitable outcomes is unlikely to be realized unless trends change in selection of CV fellows and program directors (PDs).
View Article and Find Full Text PDF